by app | Sep 27, 2017 | news
News read more Claudio Albrecht becomes interim CEO of Stada AG On September 27, 2017 the Supervisory Board of STADA Arzneimittel AG appointed Dr. Claudio Albrecht as new Chairman of the Executive Board with immediate effect. Dr. Albrecht succeeds...
by app | Apr 1, 2017 | news
News read more APP advises consortium on Stada Funds advised by Bain Capital Private Equity, LP (“Bain Capital”) and by Cinven Partners LLP (“Cinven”), announced the intention to launch a voluntary public takeover offer (the “Takeover Offer”) for all...
by app | Mar 1, 2017 | news
News read more Sean Bowler joins APP We are delighted to announce that Sean Bowler joins APP as Partner. Sean is an engineer who has been Head of Global Engineering and HSE in several major pharmaceutical companies. He has successfully developed and...
by app | Aug 1, 2016 | news
News read more Claudio Albrecht gets appointed as non-executive director of Ino Holdco Ino Holdco S.A.R.L appointed Claudio Albrecht as non-executive Director. Ino Holdco is an entity controlled by APAX Partners and is the holding company of Neuraxpharm,...
by app | Jun 1, 2016 | news
News read more APP advises a leading PE house on the acquisition of a boutique generic company APP was appointed to act as an industry advisor to a leading PE house for the acquisition of a mid sized boutique generic company. The company acquired is a...
by app | Jun 1, 2016 | news
News read more APP advises leading Middle East pharmaceutical player in establishing an Oncology JV APP was appointed by a leading Middle East pharmaceutical company to advise them on creating an Oncology business in Iran. The project included product...
